Parkinson's disease: a dual-hit hypothesis

被引:716
作者
Hawkes, C. H. [1 ]
Del Tredici, K.
Braak, H.
机构
[1] Queens Hosp, Essex Neurosci Ctr, Romford RM7 0AG, Essex, England
[2] Goethe Univ Frankfurt, Inst Clin Neuroanat, D-6000 Frankfurt, Germany
关键词
aetiology; autonomic regulation; olfaction; Parkinson's disease;
D O I
10.1111/j.1365-2990.2007.00874.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Accumulating evidence suggests that sporadic Parkinson's disease has a long prodromal period during which several non-motor features develop, in particular, impairment of olfaction, vagal dysfunction and sleep disorder. Early sites of Lewy pathology are the olfactory bulb and enteric plexus of the stomach. We propose that a neurotropic pathogen, probably viral, enters the brain via two routes: (i) nasal, with anterograde progression into the temporal lobe; and (ii) gastric, secondary to swallowing of nasal secretions in saliva. These secretions might contain a neurotropic pathogen that, after penetration of the epithelial lining, could enter axons of the Meissner's plexus and, via transsynaptic transmission, reach the preganglionic parasympathetic motor neurones of the vagus nerve. This would allow retrograde transport into the medulla and, from here, into the pons and midbrain until the substantia nigra is reached and typical aspects of disease commence. Evidence for this theory from the perspective of olfactory and autonomic dysfunction is reviewed, and the possible routes of pathogenic invasion are considered. It is concluded that the most parsimonious explanation for the initial events of sporadic Parkinson's disease is pathogenic access to the brain through the stomach and nose - hence the term 'dual-hit'.
引用
收藏
页码:599 / 614
页数:16
相关论文
共 159 条
[1]   Excessive daytime sleepiness and subsequent development of Parkinson disease [J].
Abbott, RD ;
Ross, GW ;
White, LR ;
Tanner, CM ;
Masaki, KH ;
Nelson, JS ;
Curb, JD ;
Petrovitch, H .
NEUROLOGY, 2005, 65 (09) :1442-1446
[2]   Frequency of bowel movements and the future risk of Parkinson's disease [J].
Abbott, RD ;
Petrovitch, H ;
White, LR ;
Masaki, KH ;
Tanner, CM ;
Curb, JD ;
Grandinetti, A ;
Blanchette, PL ;
Popper, JS ;
Ross, GW .
NEUROLOGY, 2001, 57 (03) :456-462
[3]   Sleep issues in Parkinson's disease [J].
Adler, CH ;
Thorpy, MJ .
NEUROLOGY, 2005, 64 (12) :S12-S20
[4]   Challenging conventional wisdom: The etiologic role of dopamine oxidative stress in Parkinson's disease [J].
Ahlskog, JE .
MOVEMENT DISORDERS, 2005, 20 (03) :271-282
[5]   Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia [J].
Ahlskog, JE ;
Waring, SC ;
Petersen, RC ;
Esteban-Santillan, C ;
Craig, UK ;
O'Brien, PC ;
Plevak, MF ;
Kurland, LT .
NEUROLOGY, 1998, 51 (06) :1672-1677
[6]   Chemical coding of the human gastrointestinal nervous system:: Cholinergic, VIPergic, and catecholaminergic phenotypes [J].
Anlauf, M ;
Schäfer, MKH ;
Eiden, L ;
Weihe, E .
JOURNAL OF COMPARATIVE NEUROLOGY, 2003, 459 (01) :90-111
[7]   OLFACTORY FUNCTION IN PATIENTS WITH PARKINSONS-DISEASE [J].
ANSARI, KA ;
JOHNSON, A .
JOURNAL OF CHRONIC DISEASES, 1975, 28 (09) :493-497
[8]   Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson's disease [J].
Barz, S ;
Hummel, T ;
Pauli, E ;
Majer, M ;
Lang, CJG ;
Kobal, G .
NEUROLOGY, 1997, 49 (05) :1424-1431
[9]   DYSPHAGIA AND DEMENTIA IN SUBJECTS WITH PARKINSONS-DISEASE [J].
BINE, JE ;
FRANK, EM ;
MCDADE, HL .
DYSPHAGIA, 1995, 10 (03) :160-164
[10]  
Blessing W. W., 2004, The human nervous system, P464